Zions Trust National Association’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$234K Sell
3,575
-568
-14% -$35.8K 0.34% 34
2014
Q3
$239K Sell
4,143
-100
-2% -$5.55K 0.33% 35
2014
Q2
$240K Buy
4,243
+43
+1% +$2.26K 0.34% 36
2014
Q1
$216K Buy
4,200
+200
+5% +$10.1K 0.3% 37
2013
Q4
$211K Buy
4,000
+125
+3% +$6.14K 0.29% 41
2013
Q3
$173K Hold
3,875
0.25% 42
2013
Q2
$160K Buy
+3,875
New +$169K 0.23% 42

Other funds holding ABBV

Zions Trust National Association's ABBV Position: Q4 2014 in Review

Zions Trust National Association reduced its AbbVie (ABBV) stake by 14% in Q4 2014, selling an estimated $35.8K and leaving 3,575 shares worth $234K. The position accounts for 0.34% of the portfolio, ranked #34.

Zions Trust National Association first reported a position in ABBV in Q2 2013 and has held it in 7 quarters since. The position peaked at $240K in Q2 2014. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

  • Zions Trust National Association held 3,575 shares of AbbVie worth $234K as of Q4 2014.
  • Zions Trust National Association sold 568 AbbVie shares in Q4 2014, an estimated $35.8K.
  • AbbVie made up 0.34% of Zions Trust National Association's portfolio in Q4 2014, its #34 holding.
  • Zions Trust National Association first reported a position in AbbVie in Q2 2013 and has held it in 7 quarters since.
  • Zions Trust National Association's AbbVie position peaked at $240K in Q2 2014.
  • 1,605 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Zions Trust National Association's 13F filing for Q4 2014, filed 12 Jan 2015.